Skip to main content

Table 7 SF-36 pain scale scores by group and visit

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

  

Group

P value(Between Groups)

Visit

 

UP446

250 mg/day

UP446

500 mg/day

Celecoxib

200 mg/day

Placebo

 

Baseline

Mean

8.53

7.53

8.20

7.40

0.272

 

Std Deviation

1.85

2.17

1.86

1.24

 

30 Days

Mean

7.53

7.67

8.46

7.33

0.325

 

Std Deviation

1.41

1.95

.97

2.06

 

60 Days

Mean

7.29

7.38

8.08

7.31

0.643

 

Std Deviation

1.49

2.06

1.93

1.80

 

90 Days

Mean

7.50

6.54

7.50

7.54

0.547

 

Std Deviation

2.03

1.98

2.50

1.76

 
Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us